BioMarin Pharma (BMRN) Promotes Jeff Ajer to EVP, CCO
Tweet
Share
E-mail
On December 19, 2013, the Board of Directors (the “Board”) of BioMarin Pharmaceutical, Inc. (Nasdaq: BMRN) approved a promotion for Jeff Ajer to Executive Vice President, Chief Commercial Officer. In connection with his promotion, the Board approved an increase in his base salary to $425,000 per annum, to be effective in March 2014. Additionally, the Board approved an increase to his target cash bonus under the Company’s annual bonus program to 50% of base salary, which increase will be effective for his 2014 bonus, payable in the first quarter 2015.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes BioMarin Pharmaceutical Inc. (BMRN) at Buy
- Baozun Inc. (BZUN) Appoints Catherine Zhu as CFO
- Vicinity Motor (VEV) Appoints Brent Phillips as President
Create E-mail Alert Related Categories
Management Changes, SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
